Fair value (multi-method)
Four independent methods triangulate what GILD is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$540,471.92
Method range
$26.33 – $540,471.92
median $159.28
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $540,471.92 | +414,563.13% |
| Exit multiple | — | — |
| Analyst target | $159.28 | +22.20% |
| Graham number | $26.33 | -79.80% |
- Forward DCF$540,471.92
- Exit multiple—
- Analyst target$159.28
- Graham number$26.33
Stock price
$130.34
FCF / share (TTM)
$1.95
3Y FCF CAGR
-3.1%
Fair value @ hist. growth
$32.26
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
13.8%
per year over your projection horizon
Margin of safety -304.0% vs hist-growth DCF
Historical 3Y CAGR
-3.1%
Your model implies
13.8%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -3% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | 11.4% | 9.9% | 8.1% | 5.9% | 3.1% |
| 5.4% | 12.9% | 11.5% | 9.9% | 8.0% | 5.7% |
| 6.4% | 16.1% | 15.1% | 13.8% | 12.4% | 10.8% |
| 7.4% | 19.0% | 18.1% | 17.1% | 16.0% | 14.8% |
| 8.4% | 21.7% | 20.9% | 20.0% | 19.1% | 18.1% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
Net debt
$17B
Total debt − cash
Beta
0.34
Vs market benchmark
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.93% TTM
- Dividend Profile2.47% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.